European Radiology

, Volume 23, Issue 12, pp 3456–3465 | Cite as

Quantitative MR perfusion parameters related to survival time in high-grade gliomas

  • Roberto Sanz-RequenaEmail author
  • Antonio Revert-Ventura
  • Luis Martí-Bonmatí
  • Ángel Alberich-Bayarri
  • Gracián García-Martí



To evaluate the quantitative parameters obtained from dynamic MR T2*-weighted images as predictors of survival taking into consideration the biasing effects of other survival-related covariates.


Thirty-nine patients (60 ± 14 years; survival 267 ± 191 days) with high-grade gliomas (8 grade III, 31 grade IV) were retrospectively included in the study. Additional data incorporated Karnofsky performance scale, tumour resection extension after surgery and type of treatment. Dynamic T2*-weighted MRI was acquired before treatment. Tumour curves were extracted for each voxel, and several quantitative parameters were obtained from the whole tumour volume and the 10 % maximum values. Additional image covariates included the presence of necrosis, single or multiple lesions, and tumour and oedema volumes. The relationship between quantitative parameters and survival was assessed using clusterisation techniques and the log-rank method. Cox regression analysis was used to evaluate each parameter’s predictive value.


Only the mean of the 10 % maximum values of the transfer coefficient showed an independent relationship with patient survival (log-rank chi-squared test <0.001, Cox regression P = 0.015), with higher values corresponding to lower survival rates.


High maximum transfer coefficient values show an independent statistical relationship with low survival in high-grade glioma patients. This imaging biomarker can be used as a predictor of prognosis.

Key Points

• Histological examination is the standard procedure for predicting glioma biological behaviour.

• Tumour biopsies may be biased by sample size and location.

• Dynamic T2*-weighted MRI quantitative analysis characterises tumour vasculature at the voxel level.

• High-transfer constant maximum values are independent predictors of low overall survival.


Glioma Perfusion MRI Quantitative evaluation Survival 


  1. 1.
    Folkerth RD (2004) Histologic measures of angiogenesis in human primary brain tumors. Cancer Treat Res 117:79–95PubMedCrossRefGoogle Scholar
  2. 2.
    Burger P (1986) Malignant astrocytic neoplasms: classification, pathology, anatomy, and response to therapy. Semin Oncol 13:16–20PubMedGoogle Scholar
  3. 3.
    Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P (1988) Grading of astrocytomas: a simple and reproducible method. Cancer 62:2152–2165PubMedCrossRefGoogle Scholar
  4. 4.
    Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumors. Brain Pathol 3:255–268PubMedCrossRefGoogle Scholar
  5. 5.
    Kleihues P, Cavenee WK (2000) World Health Organization classification of tumors: Pathology and genetics of tumors of the nervous system. IARC Press, LyonGoogle Scholar
  6. 6.
    Brat DJ, Parisi JE, Kleinschmidt-DeMasters BK et al (2008) Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med 132:993–1007PubMedGoogle Scholar
  7. 7.
    Kepes JJ (1994) Pitfalls and problems in the histopathologic evaluation of stereotactic needle biopsy specimens. Neurosurg Clin N Am 5:19–33PubMedGoogle Scholar
  8. 8.
    Sawaya R, Hammoud M, Schoppa D et al (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1055PubMedCrossRefGoogle Scholar
  9. 9.
    Waldman AD, Jackson A, Price SJ et al (2009) Quantitative imaging biomarkers in neuro-oncology. Nat Rev Clin Oncol 6:445–454PubMedCrossRefGoogle Scholar
  10. 10.
    Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998PubMedGoogle Scholar
  11. 11.
    Ostergaard L, Weisskoff RM, Chesler DA et al (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36:715–725PubMedCrossRefGoogle Scholar
  12. 12.
    Ostergaard L, Sorensen AG, Kwong KK et al (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 36:726–736PubMedCrossRefGoogle Scholar
  13. 13.
    Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMedGoogle Scholar
  14. 14.
    Knopp EA, Cha S, Johnson G et al (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791–798PubMedCrossRefGoogle Scholar
  15. 15.
    Sourbron SP, Buckley DL (2012) Tracer kinetic modeling in MRI: estimating perfusion and capillary permeability. Phys Med Biol 57:1–33CrossRefGoogle Scholar
  16. 16.
    Li KL, Zhu XP, Waterton J et al (2000) Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 12:347–357PubMedCrossRefGoogle Scholar
  17. 17.
    Law M, Yang S, Babb et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMedGoogle Scholar
  18. 18.
    Law M, Young R, Babb J et al (2006) Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 27:1975–1978PubMedGoogle Scholar
  19. 19.
    Johnson G, Wetzel SG, Cha S, Babb J, Tofts PS (2004) Measuring blood volume and vascular transfer constant from dynamic, T2*-weighted contrast-enhanced MRI. J Magn Reson Imaging 51:961–968Google Scholar
  20. 20.
    Mills SJ, Patankar TA, Haroon HA et al (2006) Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 27:853–858PubMedGoogle Scholar
  21. 21.
    Law M, Young RJ, Babb JS et al (2008) Gliomas. Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247:490–498PubMedCrossRefGoogle Scholar
  22. 22.
    Hirai T, Murakami R, Nakamura H et al (2008) Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. AJNR Am J Neuroradiol 29:1505–1510PubMedCrossRefGoogle Scholar
  23. 23.
    Albert FK, Forsting M, Sartor K, Adams HP, Kunze S (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45–60PubMedCrossRefGoogle Scholar
  24. 24.
    Emblem KE, Nedregaard B, Nome T et al (2008) Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 247:808–817PubMedCrossRefGoogle Scholar
  25. 25.
    Lev M, Ozsunar Y, Henson J et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 25:214–221PubMedGoogle Scholar
  26. 26.
    Calamante F, Vonken EPA, Van Osch MJP (2007) Contrast agent concentration measurements affecting quantification of bolus tracking perfusion MRI. Magn Reson Med 58:544–553PubMedCrossRefGoogle Scholar
  27. 27.
    Wong JC, Provenzale JM, Petrella JR (2000) Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 174:1147–1157PubMedCrossRefGoogle Scholar
  28. 28.
    Revert Ventura AJ, Sanz-Requena R, Martí-Bonmatí L et al (2010) Nosological analysis of MRI tissue perfusion parameters obtained using the unicompartmental and pharmacokinetic models in cerebral glioblastomas. Radiologia 52:432–441PubMedCrossRefGoogle Scholar
  29. 29.
    Zhang T, Ramakrishnon R, Livny (1996) BIRCH: an efficient data clustering method for very large databases. Proceedings of the ACM SIGMOD Conference on Management of Data, Montreal, Canada, pp 103-104Google Scholar
  30. 30.
    Scott CB, Scarantino C, Urtasun R et al (1998) Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG90–06. Int J Radiat Oncol Biol Phys 40:51–55PubMedCrossRefGoogle Scholar
  31. 31.
    Bauman G, Lote K, Larson D et al (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923–929PubMedCrossRefGoogle Scholar
  32. 32.
    Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487PubMedGoogle Scholar
  33. 33.
    Pierallini A, Bonamini M, Pantano P et al (1998) Radiological assessment of necrosis in glioblastoma: variability and prognostic value. Neuroradiology 40:150–153PubMedCrossRefGoogle Scholar
  34. 34.
    Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60PubMedCrossRefGoogle Scholar
  35. 35.
    Shin JH, Lee HK, Kwun BD et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 179:783–789PubMedCrossRefGoogle Scholar
  36. 36.
    Bulakbasi N, Kocaoglu M, Farzaliyev A et al (2005) Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 26:2187–2199PubMedGoogle Scholar
  37. 37.
    Roberts HC, Roberts TPL, Brasch RC et al (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMedGoogle Scholar
  38. 38.
    Ludemann L, Gieger W, Wurm R et al (2001) Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 11:1231–1241PubMedCrossRefGoogle Scholar
  39. 39.
    Provenzale JM, Wang GR, Brenner T et al (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR Imaging. AJR Am J Roentgenol 178:711–716PubMedCrossRefGoogle Scholar
  40. 40.
    Patankar TF, Haroon HA, Mills SJ et al (2005) Is volume transfer coefficient K(trans) related to histologic grade in human gliomas? AJNR Am J Neuroradiol 26:2455–2465PubMedGoogle Scholar
  41. 41.
    Leon SP, Folkerth RD, Black PM (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362–372PubMedCrossRefGoogle Scholar
  42. 42.
    Abdulrauf SI, Edvardsen K, Ho KL et al (1998) Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytomas. J Neurosurg 88:513–520PubMedCrossRefGoogle Scholar
  43. 43.
    Law M, Young R, Babb J, Pollack E, Johnson G (2007) Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 28:761–766PubMedGoogle Scholar
  44. 44.
    Jackson RJ, Fuller GN, Abi-Said D et al (2001) Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 3:193–200PubMedGoogle Scholar
  45. 45.
    Jain R, Narang J, Griffith B et al (2013) Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates. Acad Radiol 20:478–485PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2013

Authors and Affiliations

  • Roberto Sanz-Requena
    • 1
    Email author
  • Antonio Revert-Ventura
    • 2
  • Luis Martí-Bonmatí
    • 1
    • 3
  • Ángel Alberich-Bayarri
    • 1
  • Gracián García-Martí
    • 1
    • 4
  1. 1.Radiology DepartmentHospital Quirón ValenciaValenciaSpain
  2. 2.Radiology DepartmentHospital de ManisesManisesSpain
  3. 3.Medical Imaging AreaHospital Universitari I Politècnic La FeValenciaSpain
  4. 4.CIBER-SAMInstituto de Salud Carlos IIIMadridSpain

Personalised recommendations